Pituitary & hypothalamus

Histopathological and radiological predictors of surgical remission failure in GH-secreting pituitary adenomas

PituitaryPublished Retrospective cohort study

Authors' conclusion

T2 signal intensity helps identify granulation patterns, but it does not predict surgical remission. Surgical remission failure is associated with cavernous sinus invasion and infrasellar extension greater than 4.93 mm, indicating more aggressive GH-secreting pituitary adenomas.

Study context

Population
GH-secreting pituitary adenomas assessed for granulation pattern, tumor volume, normalized T2 signal intensity, extrasellar extension and proliferative status
Participants
107 adenomas
Exposure
Surgical remission vs non-remission at 6 months; densely (DG) vs sparsely granulated (SG) adenomas
  • DGn = 52
  • SGn = 55
Outcome
Radiological and histological predictors of surgical remission failure
Follow-up
6 months post-surgery

Main finding

As reported in the abstract

Predictors of surgical remission failure

Infrasellar extension predictive of remission failure, OR

1.186

p = 0.005

Cavernous sinus invasiveness predictive of remission failure, OR

2.997

p = 0.023

Infrasellar growth cutoff >4.93 mm for remission failure: sensitivity 58%, specificity 71%, AUC

0.67

p < 0.001

Observational data: associations, not effects.

Further findings

OutcomeP value
Surgical remission rate, SG vs DG · 6 months post-surgeryNo significant differenceP = 0.098

Granulation pattern and T2 signal intensity

T2 signal intensity distinguished DG and SG subtypes
Infrasellar extension more common than suprasellar or parasellar extension in both subtypes

Original publication

Histopathological and radiological predictors of surgical remission failure in GH-secreting pituitary adenomas. Pituitary. Published 9 February 2026. doi:10.1007/s11102-025-01635-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.